Naxitamab: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
4
Conditions studied
2
US states with sites
1
Countries
Phase breakdown
Phase 1 2
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Breast cancer | 2 |
| Anatomic Stage IV Breast Cancer AJCC v8 | 1 |
| HER2-Negative Breast Carcinoma | 1 |
| Metastatic Triple-Negative Breast Cancer | 1 |
Recruiting trials involving Naxitamab
- Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer
- Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)
Common questions
How many recruiting trials involve Naxitamab?
2 recruiting trials across 4 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.